title: Unresectable angiosarcoma treated with bevacizumab and paclitaxel.
authors.affiliation: Servicio de Dermatología Hospital Abente y Lago, Complejo Hospitalario Universitario, A Coruña, España. Electronic address: vnespereira@hotmail.com.
authors.forename: M V
authors.initials: MV
authors.lastname: Nespereira-Jato
authors.affiliation: Servicio de Dermatología Hospital Abente y Lago, Complejo Hospitalario Universitario, A Coruña, España.
authors.forename: C
authors.initials: C
authors.lastname: Peña-Panabad
authors.affiliation: Servicio de Oncología, Hospital Abente y Lago, Complejo Hospitalario Universitario, A Coruña, España.
authors.forename: M
authors.initials: M
authors.lastname: Quindós-Varela
authors.affiliation: Servicio de Dermatología Hospital Abente y Lago, Complejo Hospitalario Universitario, A Coruña, España.
authors.forename: J
authors.initials: J
authors.lastname: García-Silva
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D000068258:Bevacizumab; D004359:Drug Therapy, Combination; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006394:Hemangiosarcoma / Q000188:drug therapy*; D006801:Humans; D017239:Paclitaxel / Q000627:therapeutic use*; D012074:Remission Induction; D012535:Scalp; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000972:Antineoplastic Agents, Phytogenic; D000068258:Bevacizumab; D017239:Paclitaxel